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bypass acute kidney injury
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Abstract
Background: Acute kidney injury (AKI) is a common and serious complication of cardiac surgery using
cardiopulmonary bypass (CPB). The pathogenesis is poorly understood and the study of AKI in rodent models
has not led to improvements in clinical outcomes. We sought to determine the changes in renal medullary gene
expression in a novel and clinically relevant porcine model of CPB-induced AKI.
Results: Adult pigs (n = 12 per group) were randomised to undergo sham procedure, or 2.5 hours CPB. AKI
was determined using biochemical (Cr51 EDTA clearance, CrCl, urinary IL-18 release) and histological measures.
Transcriptomic analyses were performed on renal medulla biopsies obtained 24 hours post intervention or from
sham group. Microarray results were validated with real-time polymerase chain reaction and Western Blotting.
Of the transcripts examined, 66 were identified as differentially expressed in CPB versus Sham pig’s kidney samples,
with 19 (29%) upregulated and 47 (71%) down-regulated. Out of the upregulated and downregulated transcripts 4
and 16 respectively were expression sequence tags (EST). The regulated genes clustered into three classes; Immune
response, Cell adhesion/extracellular matrix and metabolic process. Upregulated genes included Factor V, SLC16A3
and CKMT2 whereas downregulated genes included GST, CPE, MMP7 and SELL.
Conclusion: Post CPB AKI, as defined by clinical criteria, is characterised by molecular changes in renal medulla
that are associated with both injury and survival programmes. Our observations highlight the value of large animal
models in AKI research and provide insights into the failure of findings in rodent models to translate into clinical
progress.
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Background
Acute kidney injury (AKI), defined as an acute 25%
reduction in glomerular filtration rate [1] is one of the
most serious complications post-cardiac surgery with
mortality rates of 6–19% [2-4]. The pathogenesis is poorly
understood [5] and there have been no advances in the
treatment of this condition since the development of
dialysis over 30 years ago. Where postoperative renal
dysfunction is so severe as to require dialysis, mortality
rates are as high as 63% [3]. Cardiopulmonary bypass
(CPB) is a major contributor to AKI post-cardiac sur-
gery [6]. Attempts to ameliorate this injury in clinical
studies have, to date been unsuccessful [7]. Reno-
protective strategies developed in rodent models, the
mainstay of research into AKI, have failed to translate
into clinical benefits and there is a widely acknowledged
need for the development of large animal models of AKI
with closer homology to humans [8,9]. Indeed, it is now
accepted that there is a disparity between small rodents
and humans explaining why basic research on these
models have not yielded great clinical advances [10,11].
The pig genome-sequencing project is developing fast
and providing an important resource to extend the po-
tential of the pig as a biomedical model [12]. We have
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previously noted qualitative and quantitative similarities
between post CPB acute kidney injury in swine [13,14]
and those described in a previous randomised con-
trolled clinical trial of coronary artery bypass grafting
with or without CPB [15]. We have also identified me-
dullary hypoxia and an apparently paradoxical elevation
in cellular ATP levels in the outer medulla in association
with intra-renal vasoconstriction and endothelial dysfunc-
tion in kidneys exhibiting AKI as defined clinically at
24 hours post CPB in the swine model [14]. The aim of
the current study was to investigate global transcriptomic
alterations in the renal medulla in post CPB kidneys in
this model in order to gain greater insight into the patho-
genesis of this condition.
Results
Anaesthesia, monitoring and cardiopulmonary bypass
All animals survived the study to recovery, re-anaesthesia,
re-evaluation and sacrifice. Baseline weight, serum creatin-
ine, urine output and total volume of crystalloid admi-
nistered over the course of the study were not different
between the groups (Table 1). The sham group had a sig-
nificantly lower level of fractional sodium excretion at
baseline suggesting that baseline hydration may have been
less in these animals. The mean fractional sodium excre-
tion in both groups was less than 1 in both groups how-
ever suggesting that this is unlikely to have confounded
our observations. CPB was characterised by a reduction
in mean arterial blood pressure (MABP) and circulating
haematocrit, as is typically observed clinically. Perfusion
pressures were otherwise similar at baseline, immedi-
ately post intervention and at 24 hours for both groups
(Figure 1).
Acute kidney injury
We measured the effect of CPB on renal function as
determined by measured Cr51 EDTA clearance and
calculated creatinine clearance at 1.5 and 24 hours
(Additional file 1: Figure S1). CPB reduced glomerular
filtration rate (GFR) by 33.6 ml/hr (95%CI 27.1 to 40.1),
p < 0.001 as determined by Cr51 EDTA clearance, and by
54.1 ml/hr (95%CI 22.2 to 86.0), p < 0.001, as determined
by creatinine clearance. This effect, equates to stage R in
the RIFLE classification of acute kidney injury [1]. The re-
gression coefficient for CrCl vs 51Cr-EDTA clearance was
0.74 at 90 minutes and 0.78 at 24 hours, both p < 0.001.
CPB was also associated with significant proteinuria at
24 hours (mean difference: +1.54 (95%CI 1.16 to 2.05)
mg/mmol, p = 0.003) and an increase urine IL-18 levels
(mean difference: +210.78 (95%CI 127.62 to 293.94) pg/ml,
Table 1 Baseline characteristics
Variable Sham (n = 6) CPB Alone (n = 6) P value
Weight (kg) 58.2 (2.4) 56.9 (1.7) 0.678
Serum creatinine
(mmol/L)
138.7 (13.2) 134.3 (9.4) 0.794
Creatinine clearance
(ml/min)
108.6 (8.51) 120.8 (11.25) 0.410
Urine output (ml/kg/hr) 1.27 (0.17) 1.65 (0.44) 0.437
Fractional excretion of
sodium (%)
0.27 (0.08) 0.63 (0.17) 0.080
Free water clearance
(ml/min)
−0.34 (0.20) −0.51 (0.17) 0.540
Protein/Creatinine ratio
(mg/mmol)
21.26 (1.43) 22.41 (2.68) 0.713
Albumin/Creatinine ratio
(mg/mmol)
0.22 (0.09) 0.08 (0.05) 0.215
Fluid requirement (ml) 4833 (105.4) 5500 (223.6) 0.022
Metaraminol dose (mg) 0.02 (0.02) 1.7 (0.65) 0.109
Data represents mean (SEM).
Figure 1 Haemodynamic changes throughout the experiment.
(A) Mean arterial blood pressure and (B) central venous press in the
sham group (solid circles) and cardiopulmonary bypass group (cross)
over the course of the experiment. Data represents mean (SEM).
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p < 0.001) a specific marker of AKI used in clinical studies.
Acute Tubular Necrosis (ATN) was quantified using an
established scoring system [16] by a blinded renal his-
topathologist. This demonstrated no ATN in post CPB
kidneys despite the biochemical evidence of acute kidney
injury. There was however widespread phenotypic change
evident with renal tubular epithelial cells appearing flat-
tened and more epitheloid giving an appearance of tubular
dilatation (Mean difference in tubular diameter +2.13
(0.07 to 4.13) μm, p = 0.044).
Analysis of differentially expressed genes
We used the Affymetrix GeneChip Porcine Genome
Array in this study as it provides coverage of 20,201
porcine genes (www.affymetrix.com/estore). Of the tran-
scripts examined, 66 were identified as differentially
expressed in CPB versus Sham pig’s kidney biopsies
(P < 0.05; 1.6 fold), with 19 (29%) up-regulated and 47
(71%) down-regulated (Figure 2, Table 2). The regu-
lated genes clustered into three classes cell adhesion/
extracellular matrix, immune response and metabolic
process (Table 3). Most of the upregulated genes
belonged to the metabolic process cluster. The down-
regulated genes belonged to cell adhesion/extracellular
matrix and immune response clusters. Collectively,
these changes indicate transcriptomic remodelling in
the kidney’s medulla following CPB.
Gene networks analysis
The HiMAP (Human Interactome Map) browser was
used to explore the human literature-confirmed protein-
protein interaction maps and the networks of interac-
tions where the regulated genes are potentially involved.
The analysis looked for the direct pathways connecting
genes. The Biological Association Network of the down-
regulated genes included three major nodes; PECAM1
platelet/endothelial cell adhesion molecule 1 (PECAM1,
also called CD31), selectin L (SELL, also called CD62L)
and Fc fragment of low affinity IIIb, receptor (FCGR3B).
Each of these genes interacts with other proteins (13, 12
and 7 interactions respectively; Figure 2B).
Validation of microarray with real-time PCR
Microarray results were confirmed by using real-time
quantitative PCR on 7 selected genes that demonstrated
the highest differential gene expression. The changes in
expression levels of GST, MMP7, SELL, CKMT2 and
SLC16A3 showed a very high degree of correlation with
the microarray data (Figure 3). The other two examined
genes showed a tendency to change similar to that of
microarray experiment although these did not reach
statistical significance (Figure 3).
Validation of microarray with western blotting
Despite being greatly informative, changes in mRNA levels
are insufficient to predict protein expression levels. We
therefore went onto assessing the protein levels of some
of the identified genes. We semi-quantitatively assessed
protein levels in kidney medulla of CPB and Sham animals
using Western blotting. CKMT2 and CPE showed signi-
ficant increase and decrease in CPB compared to Sham
samples respectively (Figure 4A, D). These protein expres-
sion changes were similar to those observed at the mRNA
level. Factor 5, SLC16A3 and SELL showed no significant
alteration in protein level following CPB (Figure 4B, C, E).
However, we noted a tendency to increase by CPB for
Factor 5.
Discussion
This microarray-based gene expression profiling study
confirms the existence of transcriptomic changes of the
renal medulla in response to post-CPB AKI. The upregu-
lated genes belonged to the metabolic process cluster.
The downregulated genes belonged to cell adhesion/ex-
tracellular matrix and immune response clusters. Gene
members of these clusters belonged to both injury and
survival programmes. These changes indicate a mixed
transcriptomic response of kidney’s medulla following
CPB. It has been previously suggested that in response to
early ischemia/reperfusion injury, a concomitant injuring
and regenerating programmes of tubule cells are triggered
[17]. This response of renal medullary tubular cells to
ischemia implicates cell death, dedifferentiation of viable
cells, proliferation, differentiation, and restitution of a
normal epithelium [18,19].
Strengths and limitations of the study
The porcine model has several advantages over rodent
models of acute kidney injury; there is significant hom-
ology between human and porcine renal anatomy,
haemodynamics and function [20] and it is possible to
examine the in vivo response to an injury that has direct
clinical relevance such as CPB as well as any potential
therapy. Previous studies have shown gene expression
alterations in the kidney after ischemic AKI in murine
and rat models [21-23]. However, findings in rodent
models of AKI have failed to translate into clinical bene-
fits principally due the poor homology between rodent
and human renal anatomy and function, greater toler-
ance to ischaemia in humans and the difference in the
nature of the experimental renal insult versus clinical
scenarios associated with kidney injury [20]. Indeed, there
are still questions regarding rodent models adequacy as a
paradigm for human acute kidney injury [8]. This is the
first study to examine gene expression change in the kid-
ney of a large animal model that exhibits AKI in response
to a common clinical injury; CPB. Indeed the porcine
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model used displays significant homology to cardiac
surgery patients [13,15]. This preliminary study is an
important step towards improving our understanding
of the molecular changes associated with post-CPB AKI,
and helps developing reno-protective strategies in cardiac
surgery.
Additionally, we elected to focus our analysis to the
renal medulla because: 1. Pathological changes (ATN) in
this anatomical region of the kidney have been part of
the established paradigm of clinical AKI for many years
[24]. 2. We failed to detect any ATN in this region of
the kidney, as might have been expected on the basis of
findings in rodent models, and in fact demonstrated that
cellular ATP was preserved in the renal medulla despite
the presence of refractory vasoconstriction, severe medul-
lar hypoxia and diminished GRF [14]. 3. This region has
fewer distinct anatomical compartments as compared to
say the inner cortex where glomeruli and multiple prox-
imal and distal tubular cell types are in close proximity,
aiding interpretation.
A limitation of our study is that this model only re-
flects less severe AKI; the changes n renal clearance
that we have described equate to the ‘Risk’ stage of the
RIFLE classification, now considered as Stage 1 AKI
in the recent Kidney Diseases Improving Global Outcomes
consensus definition [25]. Animal recovery with re-evalu-
ation at 24 hours is a key component, and strength of the
current model as our previous studies have shown that
changes in filtration immediately post CPB are not indica-
tive of later pathophysiology [26,27]. However reproducible
recovery mandates that the nature of the injury sustained
by study subjects is less severe. This limitation notwith-
standing Stage 1 AKI has important prognostic implica-
tions in cardiac surgery. Moreover our model is unique in
Up-regulated
Down-regulated
A 
19 Genes 
47 Genes 
B 
Figure 2 Differentially expressed genes and gene networks analysis. (A) Pie-chart of the regulated genes in CPB compared to Sham animals
(≥1.6 fold). Three quarters of genes were down-regulated and a quarter up-regulated. (B) Biological Association Networks of down-regulated
genes. Human literature-confirmed protein-protein interaction map of the identified genes is shown. The big disc nodes are the altered genes.
The small nodes are the interacting partners that are not altered in the experiment.
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Table 2 Genes exhibiting 1.6-fold or greater change of expression in CPB versus Sham animals
Probe set ID Symbol Gene Fold P value Gene ID
Ssc.17934.1.S1_at STARD10 StAR-related lipid transfer (START) domain containing 10 2.540 up 0.00475 100511029
Ssc.11208.1.S1_at LOC100625243 Ig kappa chain V-II region RPMI 6410-like 2.413 up 0.0297 100625243
Ssc.7981.1.A1_at ACOX3 Acyl-CoA oxidase 3, pristanoyl 2.263 up 0.00402 100523005
Ssc.22067.1.A1_at SLC16A3 Solute carrier family 16, member 3 (monocarboxylic acid transporter 4) 2.223 up 0.00619 100158243
Ssc.15822.1.S1_at F5 Coagulation factor V 2.079 up 0.00974 397217
Ssc.19237.1.S1_at 2.078 up 0.0433
Ssc.14462.1.S1_a_at CKMT2 Creatine kinase, mitochondrial 2 (sarcomeric) 1.988 up 0.0281 733602
Ssc.5607.1.S1_at ALDH4A1 Aldehyde dehydrogenase 4 family, member A1 1.920 up 0.0458 100820830
Ssc.25191.1.S1_at LOC100525039 Protein FAM195A-like 1.914 up 0.0414 100525039
Ssc.15778.1.S1_s_at LOC100736878 Ig kappa chain V-II region RPMI 6410-like 1.827 up 0.00896 100736878
Ssc.4742.1.S1_at TUBA4A Tubulin, alpha 4a 1.765 up 0.0323 100151951
Ssc.24386.1.S1_a_at LOC100620791 Thyroid receptor-interacting protein 6-like 1.737 up 0.0432 100620791
Ssc.8946.1.A1_at 1.714 up 0.0335
Ssc.5204.1.S1_at CDA Cytidine deaminase 1.713 up 0.0169 100515954
Ssc.8646.1.A1_at 1.668 up 0.0079
Ssc.7654.1.A1_at LOC100621324 Heat shock-related 70 kDa protein 2-like 1.644 up 0.00441 100621324
Ssc.21893.1.S1_at LOC100513653 Transmembrane protein C2orf18-like 1.643 up 0.0164 100513653
Ssc.9500.1.A1_at 1.633 up 0.0257
Ssc.4767.1.S1_at ACO1 Aconitase 1, soluble 1.606 up 0.00884 100628006
Ssc.14425.1.A1_at 1.606 down 0.0316
Ssc.13320.1.A1_at MIR186 MicroRNA mir-186 1.613 down 0.0415 100316566
Ssc.31011.1.A1_at 1.614 down 0.0417
Ssc.11302.1.S1_at COL3A1 Collagen, type III, alpha 1 1.617 down 0.0432
Ssc.8321.1.A1_at 1.627 down 0.0473
Ssc.18553.1.S1_at 1.627 down 0.0415
Ssc.5202.1.A1_at LOC100525593 Uncharacterized LOC100525593 1.628 down 0.0376 100525593
Ssc.11992.1.A1_at CLU Clusterin 1.637 down 0.0375 397025
Ssc.25145.1.S1_at 1.669 down 0.0248
Ssc.14558.1.S1_at PECAM1 Platelet/endothelial cell adhesion molecule 1.670 down 0.0146 396941
Ssc.6154.1.S1_a_at LOC100622481 Uncharacterized LOC100622481 1.671 down 0.035 100622481
Ssc.1950.1.A1_at LOC100513240 GRAM domain-containing protein 1C-like 1.672 down 0.0441 100513240
Ssc.6050.1.A1_at PECAM1 Platelet/endothelial cell adhesion molecule 1.676 down 0.0439 396941
Ssc.21972.1.A1_at LOC100523311 T-complex protein 11-like protein 2-like 1.676 down 0.0301 100523311
Ssc.2011.1.A1_at LOC100152637 Protein kinase C theta 1.677 down 0.0282 100152637
Ssc.15296.2.S1_at CD53 Leukocyte surface antigen CD53 1.688 down 0.017 100152398
Ssc.3975.2.A1_at 1.694 down 0.0107
Ssc.12229.1.S1_at LOC100520933 Cyclin-dependent kinases regulatory subunit 2-like 1.699 down 0.00553 100520933
Ssc.31095.1.A1_at LOC100624138 Cholinesterase-like 1.700 down 0.0246 100624138
Ssc.30685.1.A1_at LOC100511051 Protein FAM114A2-like 1.707 down 0.0268 100511051
Ssc.22075.2.A1_at SELL Selectin L 1.711 down 0.00383 100127147
Ssc.31071.1.A1_at 1.719 down 0.0136
Ssc.15283.1.A1_at KDELR3 KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3 1.730 down 0.00283 100514523
Ssc.11006.2.A1_at 1.748 down 0.0275
Ssc.19640.1.A1_at LOC100152827 Similar to high affinity immunoglobulin E receptor alpha subunit 1.751 down 0.00646 100152827
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that it develops clinically defined AKI, as reflected by
reductions in renal clearance, proteinuria and the release
or the AKI biomarker IL-18 [28]. A second limitation is
that alterations in gene expression identified by genechip
analysis are not necessarily predictive of downstream
functional and/or pathophysiologic networks. Thus, al-
though we have confirmed an upregulation of select meta-
bolic process genes and a down-regulation of extracellular
matrix genes at the mRNA level and even at the pro-
tein level, multiple additional posttranscriptional and
posttranslational events may be required to fully im-
plicate these factors in the acute kidney injury follow-
ing CPB.
Translational relevance
Our data showed changes in gene expression of enzymes
involved in metabolism. This finding is somewhat similar
to previous studies [17,29]. However, in our study, most
metabolism cluster genes were upregulated, whereas
metabolism genes were mostly downregulated by
ischemia-reperfusion in the other studies [17,29]. This
could be explained by the difference in the model em-
ployed. Indeed, in our model, CPB was used to trigger
kidney injury while direct renal ischemia-reperfusion was
used in the other studies to initiate kidney injury [17,29].
Additionally the mouse model expression studies used the
whole kidney as opposed to our use of renal medulla in
this study. Whereas rodent models typically demonstrate
hypoxia, medullary ATP depletion, and ATN following
warm ischaemia and reperfusion, this was not observed in
our model. Indeed, in previous studies we have demon-
strated increased medullary ATP levels, concomitant with
hypoxia in the outer medulla and cortical vasoconstriction
[14,30]. This is perhaps attributable to the reduced solute
delivery to the distal nephron attendant to acute reduc-
tions in GFR. An alternative explanation for these differ-
ences is that post CPB AKI is not characterised by ATN.
Table 2 Genes exhibiting 1.6-fold or greater change of expression in CPB versus Sham animals (Continued)
Ssc.30893.1.A1_at LOC100511723 PTB domain-containing engulfment adapter protein 1-like 1.807 down 0.0308 100511723
Ssc.28613.1.S1_at 1.839 down 0.0227
Ssc.11775.1.S1_at RPS15 Ribosomal protein S15 1.848 down 0.00553 397607
Ssc.21138.1.S1_at HUS1 HUS1 checkpoint homolog (S. pombe) 1.881 down 0.0022 100192318
Ssc.15540.1.A1_at 1.886 down 0.0338
Ssc.167.2.S1_a_at FCGR3B Fc fragment of IgG, low affinity IIIb, receptor (CD16b) 1.901 down 0.0393 397684
Ssc.4368.3.S1_at FBXO32 F-box protein 32 1.923 down 0.00578 733657
Ssc.3070.1.S1_at 1.923 down 0.0163
Ssc.11437.1.A1_at LOC100525762 DNA damage-inducible transcript 4-like protein-like 1.946 down 0.0388 100525762
Ssc.7122.1.A1_at 1.959 down 0.029
Ssc.17337.1.S1_at TLR2 Toll-like receptor 2 2.002 down 0.0452 396623
Ssc.7628.1.A1_at CSDE1 cold shock domain containing E1, RNA-binding 2.015 down 0.0383 100153226
Ssc.12776.1.A1_at SELL Selectin L 2.030 down 0.00984 100127147
Ssc.9217.1.S1_at 2.058 down 0.0425
Ssc.29716.1.A1_at 2.095 down 0.0449
Ssc.548.1.S1_a_at MMP7 Matrix metallopeptidase 7 (matrilysin, uterine) 2.239 down 0.0106 397411
Ssc.24173.1.S1_at LOC100739731 protein shisa-2 homolog 2.401 down 0.0484 100739731
Ssc.4953.1.A1_at 2.420 down 0.00875
Ssc.8868.1.S1_at FCGR2B Fc fragment of IgG, low affinity IIb, receptor (CD32) 2.527 down 0.0178 613131
Ssc.5464.1.A1_at CPE Carboxypeptidase E 2.657 down 0.0126 100037304
Ssc.31013.1.A1_s_at 2.666 down 0.00663
Ssc.9778.1.S1_at LOC100049692 Proteoglycan 1 precursor-like 3.328 down 0.0377 100049692
Ssc.10606.1.S1_at 4.615 down 0.00588
Ssc.16377.1.A1_at GSTA2 Glutathione S-transferase alpha 2 8.984 down 0.00835 396850
Table 3 Functional pathways represented by the genes
altered in CPB versus Sham animals
Function Molecules
Immune response CLU, CD53, FCGR3B, TLR2, FCGR2B, PECAM1
Cell adhesion/
extracellular matrix
FACTOR V, TUBA4A, COL3A1,
CLU, PECAM1, SELL, MMP7
Metabolic process STARD10, ACOX3, SLC16A3, CKMT2, ALDH4A1,
CDA, ACO1, CHOLINESTERASE-LIKE, CPE,
GSTA2, KDELR3
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Figure 3 Confirmation of the microarray results of changed genes in CPB versus Sham animals. Changes in mRNA expression of CPE, GST,
MMP7, SELL, CKMT2, F5 and SLC16A3 were verified in 10 pigs (5 CPB and 5 Sham; n = 5) by quantitative real-time-PCR. Results are shown as mean
(±standard error of the mean, SEM) fold-change. *P < 0.05, ***P < 0.001.
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Figure 4 Western blotting of identified gene products in kidney medulla of CPB and Sham animals. Tissues from 10 pigs (5 CPB and 5
Sham; n = 5) were lysed to isolate protein content and Western blotting analysis performed probing for CKMT2 (A), Factor 5 (B), SLC16A3 (C), CPE
(D), SELL (E), and GAPDH. CKMT2 was significantly up-regulated in CPB compared to Sham samples. CPE was significantly down-regulated in CPB
compared to Sham samples. CKMT2, Factor 5, SLC16A3, CPE and SELL bands were normalised to GAPDH levels. Data are mean ± SEM, * = p < 0.05.
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This may also explain the failure of therapies developed in
rodents to improve prognosis in cardiac surgery patients
with AKI and highlights the value of large animal models
as tools for translation.
In the validation experiments, gene expression alteration
of selected genes by real-time PCR showed a very high
degree of correlation with the microarray data suggesting
that the changes of expression observed by genechip are
most likely real. However the degree of correlation be-
tween the changes at the mRNA and protein levels was
lower. This may be due to the common delay between
transcription and protein synthesis.
The metabolism process enzyme with the largest
observed upregulation was Acyl-CoA oxidase (ACOX3).
ACOX3 is a key peroxisomal enzyme catalyzing the
production of hydrogen peroxide during peroxisomal
beta-oxidation of fatty acids. Fatty acid beta-oxidation
and lipid peroxides are increased in chronic renal in-
flammation in rodents where farnesyl transferase inhib-
ition modulates peroxisome enzyme activities thereby
alleviating oxidative stress [31]. ACOX3 may therefore
be important in redox signaling in the renal medulla
after CPB, implying that oxidative stress may have a
complex role in both injury and survival signaling in
response to injury.
Another upregulated metabolism enzyme is Aconitase 1
(ACO1 or IRP1). ACO1 is a bifunctional protein that can
exist as a functional cytosolic aconitase when it binds an
iron-sulfur cluster, interconverting citrate to isocitrate, or
as an apoprotein that can bind iron Responsive Elements
to regulate the expression of mRNAs encoding proteins
involved in iron homeostasis [32]. Changes in iron metab-
olism are central to cellular injury and survival in AKI
[33]. A member of the monocarboxylate transporter fam-
ily, solute carrier family-16 member 3 (SLC16A3), was
also upregulated in the kidney medulla following CPB.
SLC16 family members are involved in a wide range of
pathways including energy metabolism, and are involved
in the transport of lactic acid, pyruvate and ketones across
the plasma membrane. Another member of the monocar-
boxylate transporter family, SLC16A7, was shown to be
down regulated following renal ischemia-reperfusion in
mouse [29], however as stated above this may be attrib-
uted to differences in the degree of injury and timing of
the genomic analysis post injury.
Factor V (F5), a gene encoding an essential cofactor of
the blood coagulation cascade, showed an upregulation
following CPB. A recent study investigated the role of
Factor V in diabetic nephropathy and demonstrated pro-
tective effect of factor V in diabetic nephropathy [34]. The
increase of Factor V in our study could be part of a regen-
erating programme initiated in response to CPB.
CKMT2, a member of the creatine kinase isoenzyme
family, showed a significant upregulation by CPB at the
mRNA and protein levels. Mitochondrial creatine kinase
(MtCK) is responsible for the transfer of high-energy phos-
phate from mitochondria to the cytosolic carrier, creatine.
It has been shown that creatine kinase-deficient hearts
exhibit increased susceptibility to ischemia-reperfusion
injury and impaired calcium homeostasis [35], thus de-
monstrating a key role of an intact creatine kinase system
for maintenance of Ca2+ homeostasis and withstanding
ischemia-reperfusion injury. In our study, the increase
of CKMT2 by CPB suggests a regenerating role for
this factor.
The microarray data showed that Aldehyde dehydro-
genase 4 (ALDH4A1) was increased 24 hours post CPB.
It has been demonstrated that over-expression of
ALDH4 in H1299 cells, resulted in significantly lower
intracellular reactive oxygen species (ROS) levels than
control cells after treatment with hydrogen peroxide or
UV [36]. Additionally ALDH4 is a p53-induced gene
with a protective role in cellular stress [36]. Therefore
ALDH4A1 could play a regenerating role in our model.
Glutathione S-transferase alpha 2 (GST) gene expres-
sion showed the greatest relative reduction. Cytosolic
and membrane-bound forms of GST function in the de-
toxification of carcinogens, therapeutic drugs, toxins and
products of oxidative stress, by conjugation with gluta-
thione. The alpha class of these enzymes also exhibit
glutathione peroxidase activity thereby protecting the
cells from reactive oxygen species and the products of
peroxidation [37]. Reduced expression of GST in response
to CPB may therefore indicate increased susceptibility to
cellular injury. In an apparent paradox urine levels of
GST have been identified as potential biomarkers of acute
kidney injury. It is suggested that this reflects membrane
permeability of damaged tubular cells, with some studies
suggesting greater diagnostic accuracy for more severe
AKI. In contrast the severity of AKI is mild to moderate
in the current model and epithelial necrosis is not evi-
dent. We noted a decrease in Glutatione S-transferase
(GSTA2) in response to CPB. However, Yoshida et al.
reported an increase in GST following renal ischemia-
reperfusion [29]. It is important to note that Yoshida
et al. analyzed the whole kidney and not only the medulla
as in our study.
The low affinity receptor for the Fc region of gamma
immunoglobulins (IgG), FCGR3B, had a decreased ex-
pression following CPB-AKI. A recent study showed that
impaired immune complex clearance arising from FCGR3B
deficiency contributes to the pathology of systemic scler-
osis, and FCGR3B copy number variation is a common
risk factor for systemic autoimmunity [38]. Our data
indicates that a reduction of FCGR3B expression may be
involved in AKI injury following CPB.
Platelet/endothelial cell adhesion molecule 1 (PECAM1)
was downregulated by CPB in this study. The encoded
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protein is a member of the immunoglobulin superfamily.
In previous studies [14,26] we have shown that loss of
endothelial PECAM-1 expression, in association with re-
duced expression of other important endothelial cell-cell
adhesion molecules is associated with endothelial and
glycocalyceal injury. These changes are associated with
endothelial permeability and dysfunction [14,26].
Carboxypeptidase E (CPE) expression was decreased at
the mRNA and protein level by CPB. Interestingly, CPE
degradation contributes to palmitate-induced beta-cell
ER stress and apoptosis [39]. Reduced CPE expression
may therefore increase cellular susceptibility to injury.
PECAM1 interacts indirectly with CPE through THBS1-
CD47 ligand receptor axis. The THBS1-CD47 axis con-
trols a number of important cellular processes including
production of reactive oxygen species. It has recently been
suggested that CD47 promotes apoptotic cell death in
renal IRI [40]. Additionally, CD47-dependent pathway
is involved in platelet adhesion on inflamed vascular
endothelium under flow [41]. Our data did not show ex-
pression changes of THBS1 and CD47 levels. However
we noted a decrease of two factors, CPE and PECAM1
that interact with THBS1-CD47 axis.
The matrix metalloproteinase 7 (MMP-7) decreased
by post-CPB AKI. MMP-7 is a protease that targets
extracellular proteins [42] and is involved in tissue remod-
eling [43-46]. The reduction of MMP-7 expression could
indicate a decrease in the remodeling capacity of the
kidney following post CPB AKI.
Selectin L (SELL), a cell surface adhesion molecule,
showed an expression decrease following CPB. Interest-
ingly, it’s been demonstrated that transient expression of
SELL in cardiac mesoangioblasts induced 2-fold increase
in their transmigration and homing to the damaged heart
[47] suggesting SELL implication in tissue repair. In our
model, the expression decrease of SELL could indicate the
kidney’s susceptibility to the injurious programme trig-
gered by CPB.
Conclusion
In conclusion, this study has characterised the transcripto-
mics changes in a model of post-CPB acute kidney injury
with potential relevance to clinical settings. It has identi-
fied previously unreported complexity in the transcrip-
tomic changes implicated in post-CPB kidney dysfunction.
These differ significantly from rodent studies that typic-
ally evaluate genomic changes in entire kidneys, and in
response to stimuli not commonly observed in clinical
practice. Our observations highlight the value of large
animal models in AKI research and provide insights into
the failure of findings in rodent models to translate into
clinical progress. Ultimately, our findings may contribute
to the successful development of novel reno-protective
strategies in cardiac surgery.
Methods
Twelve adult, female, farm-bred, Large White-Landrace
crossbred pigs weighing 50–70 kg were used in this pilot
study. Animals received care in accordance with and under
licence of the UK Home Office (Scientific Procedures) Act
1986. The investigation conforms to the Guide for the
Care and Use of Laboratory Animals published by the US
National Institutes of Health (NIH Publication No. 85–23,
revised 1996). The study had received local (University of
Bristol) institutional review board approval, and was con-
ducted under UK Home Office License PPL 30/2522. The
two groups received identical diet and unlimited access to
water. Food, but not water, was restricted on the day of
surgery.
Intervention
We randomised animals (n = 6 per group) to: Group 1.
Sham, 2.5 hours under general anaesthesia with neck
dissection, Group 2. CPB, 2.5 hours of CPB via neck
dissection, under general anaesthesia. A CPB time of
2.5 hours corresponds to prolonged CPB, a recognised
risk factor for post cardiac surgery AKI that has been
shown to result in significant kidney injury in our previous
work [14,30]. Sham animals underwent identical anaes-
thetic induction and maintenance and surgical dissection,
and systemic heparinisation to those undergoing CPB.
Anaesthesia and CPB were performed by a modification
of our protocol described previously [14,30]. Post pro-
cedure animals were recovered, re-anaesthetised and re-
evaluated after 24 hours. Nephrectomy was performed
prior to euthanasia.
Acute kidney injury
Biochemical markers
51Cr-EDTA clearance was measured for 90 min pre-CPB
and then at 90 min and 24 hours post CPB using single
bolus 51Cr-EDTA injections with clearance determination
obtained using the slope–intercept method as previously
described [13]. Briefly, 4 ml of blood was extracted as a
baseline measurement. Then 3.7 MBq of 51Cr-EDTA
(Amersham, UK) was injected into a central vein. After
injection, serial blood samples for analyses (4 ml) were
then obtained over 90 min to calculate the plasma clear-
ance curve. The blood was centrifuged (3000 × g for
10 min) and 3 ml of plasma extracted for scintillation
counting of 51Cr-EDTA (gamma counter 15 min per
sample). The radioactivity of the 51Cr-EDTA was measured
together with a standard sample prepared in combination
with that given to the pig. Clearance (Cl) of the marker
was expressed as Cl =Q/AUC (ml min − 1), where Q =
injected activity, AUC (total area under plasma clearance
curve) = A/k1 + B/k2, where A and B are the zero time
intercepts of the two exponentials and k1 and k2 the
respective rate constants.
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Creatinine clearance (CrCl), free water clearance and
fractional sodium excretion were calculated from serum
samples and urine samples taken over three time periods;
90 minutes pre-CPB; 90 minutes post weaning from CPB,
and 90 minutes at 24 hours post CPB, using accepted
formulae [48] as previously described [15].
Levels of IL-18, a specific marker of acute kidney
injury detected in the urine >12 hours following renal
injury [49], were measured in urine samples using ELISA
(Bender MedSystems, Vienna, Austria). The urinary pro-
tein-to-creatinine ratio was determined by immunoturbidi-
metry on the Cobas Mira (Koni Inst, Sweden). Differences
between groups were calculated using unpaired t-Tests
using SPSS 14.0 (SPSS Inc, Chicago, Ill, USA). P
values <0.05 were considered to be statistically significant.
Histological markers
Formalin fixed, paraffin embedded, 5 μm transverse renal
sections stained with haematoxylin and eosin were scored
for renal tubular injury and inflammation by an experi-
enced renal pathologist blinded to the experimental condi-
tions, as described previously [50,51].
Analysis of differentially expressed genes
To assess the effect of CPB on gene expression changes
in the renal medulla, we compared pigs undergoing CPB
versus a Sham group of pigs (n = 3 for each group). The
porcine kidney was harvested via laparotomy, and imme-
diately post ligation of the renal artery the organ was cut
transversely into 8 roughly equal sections. Each section
was then further sectioned into blocks of cortical, and
outer medullary tissue each approximately 0.5 cm in
diameter. The anatomical demarcations of these areas
are very clear in fresh tissue, and the anatomical lo-
calisation of the biopsies has been confirmed in our
previous studies. Each section was then placed in a cryo-
tube, snap frozen in liquid nitrogen and stored at −80°C
until analysis.
RNA extraction
Tissue was mechanically homogenized in lysis reagent
(Qiagen, Crawley, UK) and Total RNA was purified with
RNeasy Kit (Qiagen) and eluted into 30 μl of RNase-free
water. The concentration and purity of the total RNA
samples were assessed by spectrophotometry (Nanodrop,
Wilmington, DE) and further analyzed for integrity with
a Bioanalyzer 2100 with RNA 6000 Nano Assay (Agilent
Technologies, Stockport, U.K.).
Gene microarrays
Kidney medulla total RNAs (1 μg) from individual
animals were used to generate biotinylated cRNAs. The
quantity and size distribution of purified cRNA was
assessed on a Bioanalyzer 2100 using RNA 6000 Nano
Assay (Agilent Technologies) to ensure that the cRNA
amplification was successful. Target fragmentation was
achieved by incubation at 94°C for 35 min in fragmen-
tation buffer (40 mM Tris-acetate, pH 8.1/100 mM
KOAc/30 mM MgOAc). The size distribution of the
fragmented labelled transcripts was assessed on the Agi-
lent Technologies Bioanalyzer 2100 using the RNA 6000
Nano Assay. These cRNAs samples were used for hybrid-
isation to separate Affymetrix GeneChip arrays. For each
experimental group, 3 samples from individual animals
were processed. Hybridisation of the labelled cRNA to the
Affymetrix GeneChip Porcine Genome Array was carried
out for 16 h in the Affymetrix GeneChip Hybridization
Oven 640. Then GeneChip arrays were stained and washed
on the GeneChip Fluidics Station 450 (Affymetrix). The
fluorescent signals were detected with an Affymetrix
GeneChip Scanner 3000 and stored as high-resolution
fluorescence intensity data file. These data were initially
analysed with Affymetrix GeneChip operating soft-
ware GCOS 1.2, which generates an expression re-
port file that lists the quality control parameters. All
of these parameters were scrutinized to ensure that
array data had reached the necessary quality stan-
dards (scaling factor of <3-fold; average background
values at 20–100 and the ratio of 3′:5′ signal no more
than 3 for housekeeping genes GAPDH and β-actin). The
complete MIAME-compliant datasets have been submit-
ted and accepted by Gene Expression Omnibus at the
National Center for Biotechnology Information; acces-
sion number GSE44782.
Microarray data analysis
Separate microarrays were probed with independently gen-
erated target from each tissue. Raw data (CEL files) were
uploaded into ArrayStar software version 2.1 (DNASTAR)
for normalization and statistical analysis. The robust multi-
chip analysis (RMA) algorithm was used for background
correction; quantile normalization and median polish
summarization. The statistical analysis was carried out
using ArrayStar software. A Student’s t-Test was used. P
value was set to <0.05 and transcripts were filtered on
the basis of ≥1.6-fold difference.
Gene annotations
All gene annotations were checked by using online tools
and databases: Entrez Gene (www.ncbi.nlm.nih.gov). The
DAVID (Database for Annotation, Visualization, and In-
tegrated Discovery) resource [52-54] was used for
functional annotation clustering. The HiMAP (Human
Interactome Map) browser was used to explore the human
literature-confirmed protein-protein interaction maps and
the networks of interactions where the regulated genes are
potentially involved.
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cDNA synthesis and real-time PCR
Complementary DNA was reverse transcribed from 1 μg
of total RNA using Superscript III cDNA first-strand
synthesis kit (Invitrogen, UK), diluted 2-fold and 1 μl
used in real-time PCR reactions. Primers for pig CPE,
GST, MMP7, SELL, CKMT2, F5, and SLC16A3 were
designed (Table 4) using the NCBI Primer-BLAST (Primer
3 and BLAST) resource and ordered from Sigma (UK).
Amplification and detection of specific products were
carried out with Roche Lightcycler 1.5 detection System.
Each sample was performed in duplicate. 18S mRNA was
used as endogenous control transcript in each sample.
Relative expression ratios were calculated by the relative
quantification real-time-PCR method [55]. Statistical ana-
lysis (unpaired t-test) was carried out using Instat 3 soft-
ware (GraphPad Software, Inc, La Jolla, CA) and a P value
was calculated for comparison. A P value of <0.05 was
considered statistically significant.
Western blotting
Protein levels in renal tissue were quantified by Western
blotting as previously described [56]. Briefly, total protein
extracts were prepared from kidney medulla samples,
separated on SDS polyacrylamide gel (30 μg of protein ex-
tracts) and transferred to HybondTM nitrocellulose mem-
brane (Amersham). Blocked membranes were incubated in
primary polyclonal antibodies (rabbit anti-CPE, rabbit anti-
SELL, rabbit anti-CKMT2, rabbit anti-SLC16A3, Abcam)
and monoclonal mouse anti-Factor 5 (Abcam), washed
and incubated in HRP-coupled anti-rabbit or anti-mouse
secondary antibodies (Amersham). Membranes were ex-
posed to HyperfilmTM (Amersham) and protein bands
were quantified using NIH Image J software. Statistical
analysis (unpaired t-test) was carried out using Instat 3
software (GraphPad Software, Inc, La Jolla, CA) and a P
value was calculated for comparison. A P value of <0.05
was considered statistically significant.
Additional file
Additional file 1: Figure S1. Graphs showing effect of 2.5 hours of
cardiopulmonary bypass or sham intervention on A. Cr51 EDTA Clearance
and B. Calculated Creatinine Clearance, pre intervention (Pre), and at 1.5
hours and 24 hours post intervention. Values represent mean (S.E.M).
*p < 0.01. For graphs pooled estimates for pairwise comparisons derived
from Analysis of Variance for Repeated Measures with adjustment for
baseline Cr51 EDTA Clearance estimated at 138 ml/min and Creatinine
Clearance estimated at 113 ml/min, were as follows: Cr51 EDTA;
Sham-CPB 23.5 ml/min (95%CI 3.1 to 4.0 ml/min), test for overall treatment
effect p = 0.028, test for time*group interaction p = 0.789. Creatinine
Clearance; Sham–‐CPB 54.1 ml/min (95%CI 22.2 to 86.0), test for overall
treatment effect of group p = 0.004, test for group*time interaction
p = 0.073. C. demonstrates close correlation between measured Cr51 EDTA
clearance and calculated creatinine clearance.
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